Full Year 2025 Medacta Group SA Earnings Call Transcript
Key Points
- Medacta Group SA (XSWX:MOVE) reported a strong revenue growth of 18.5% in constant currency, reaching EUR 684 million.
- The company's EBITDA margin in constant currency improved to 29%, with a year-over-year increase of 19.1%.
- Net profit increased by 31% year-over-year to EUR 95.5 million, showcasing strong financial performance.
- The Board of Directors proposed a significant dividend increase of almost 60% to CHF 1.1 per share.
- Medacta experienced robust growth across various geographies, including 42% in Latin America and 23% in Asia Pacific.
- The company faces challenges in expanding its sales force, which is crucial for capturing market transitions, especially in the U.S.
- Despite strong performance, the smaller business lines like sports medicine remain dilutive to overall margins.
- The company anticipates potential price reductions in key markets such as France, Belgium, and Japan, which could impact future growth.
- Medacta's growth requires significant capital expenditure, with EUR 137 million invested last year, which may strain resources.
- The company's guidance for 2026 indicates a more conservative revenue growth range of 10% to 14%, suggesting potential market challenges.
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the Medacta full year 2025 results conference call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Francesco Siccardi, CEO of Medacta. Please go ahead, sir.
Good morning. Welcome to Medacta Full Year 2020 Five Results Conference Call. The slides of today's presentation can be found on the Medacta Investor Relations website, along with the media release. I would like to remind all participants that the presentation includes forward-looking statements, which are subject to risks and uncertainties.
Listeners and readers are therefore encouraged to refer to the disclaimer on Slide 2 of today's presentation. So after those remarks, I will now turn to Slide number 4, of the presentation with the highlights of today's publication. We did report already our revenues, EUR 684 million with 18.5% growth in constant
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
